Regulatory Scrutiny Intensifies for Gerresheimer Shares

Germany's BaFin broadens its audit of Gerresheimer's 2024 financials and initiates a review of its 2025 half-year report, increasing regulatory pressure on the struggling stock.

Germany's financial regulator, BaFin, is escalating its examination of Gerresheimer AG. The supervisory authority has broadened an ongoing audit of the company's financial statements and has simultaneously initiated a fresh review of a separate report. This development introduces another layer of uncertainty for the company's equity, which has already been under significant pressure.

Expanding the Audit Scope

The focus of the regulatory probe is now widening. Initially launched in September 2025, the investigation is being extended. BaFin is conducting a more comprehensive analysis of the group's financial statements for 2024. In a parallel move, the authority has commenced an additional examination of the half-year financial report for 2025.

The original inquiry centered on the accounting treatment of "bill-and-hold" agreements. In such contracts, goods are invoiced but remain stored with the supplier initially. Revenue recognition rules for these arrangements are particularly stringent, often leading to complex accounting judgments. The decision to expand the probe signals the regulator's intent to look beyond this specific issue and assess other aspects of the company's balance sheet.

Market Reaction Amidst Persistent Weakness

For investors, heightened regulatory uncertainty is rarely a welcome signal. The announcement contributed to further selling pressure on the stock, despite a single-day rally. On Friday, shares managed to advance by 7.90%, closing at €16.80. However, this gain is overshadowed by a stark longer-term downtrend. Over the past month, the stock price has plummeted by 37.08%. Zooming out to a one-year view reveals a staggering decline of 78.91%.

Technical indicators paint a picture of a severely distressed security. The share price currently trades approximately 50.83% below its 200-day moving average. The 14-day Relative Strength Index (RSI) sits at 17.7, a level that typically reflects extreme oversold conditions and high market tension. This volatility is quantified by a remarkably high 30-day volatility reading of 113.05%.

The overarching sentiment remains dominated by the cloud of the expanded audit. With BaFin deepening its look into the 2024 accounts and setting its sights on the 2025 interim report, this broadening of scrutiny stands as the primary factor weighing on investor confidence surrounding Gerresheimer shares.